Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03818880 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Choroidal Response to Novel Spectacle Lens to Control Myopia Progression

Study acronym: CHERRY
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study completion date: Mar 31, 2026 to Dec 31, 2026v10
  2. Study completion date: May 1, 2024 to Mar 31, 2026v9
  3. Study completion date: May 1, 2023 to May 1, 2024v8
  4. Study completion date: Dec 28, 2022 to May 1, 2023v7
  5. Primary completion date changed from estimate of May 28, 2022 to Apr 21, 2022
    • Study completion date: Jun 28, 2022 to Dec 28, 2022
    • Start date: Dec 14, 2018 to Dec 18, 2018
    v6
Show 4 earlier versionsHide 4 earlier versions
  1. Re-verified, no change to tracked fieldsv5
  2. Primary completion date: Feb 28, 2022 to May 28, 2022
    • Study completion date: Mar 28, 2022 to Jun 28, 2022
    v4
  3. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v3
  4. Lead sponsor: [Redacted] to SightGlass Vision, Inc.v2 Show 6 more changesShow less
    • Trial status: Withheld to Recruiting
    • Primary completion date: Feb 28, 2022
    • Study completion date: Mar 28, 2022
    • Start date: Dec 14, 2018
    • Collaborators expanded, about 3 words
    • Study title shortened, about 3 words
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Diurnal variations in the thickness of the choroid have been reported in the literature, and, more recently, the role of the choroid has been studied with respect to its role in myopia (near-sightedness) progression.
Trial Details
NCT Number NCT03818880
Lead Sponsor SightGlass Vision, Inc.
Collaborators: University of Waterloo
Conditions
(from sponsor)		 Myopia, Progressive
Related terms Myopia, Myopia, Degenerative
Enrollment 10 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov